T-cell associated antigen-positive B-cell lymphoma

Leukemia and Lymphoma

Volumn 42, Issue 6, 2001, Pages 1161-1171

  Inaba, Tohru ^a   Shimazaki, Chihiro ^a   Sumikuma, Toshiya ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

B cell non Hodgkin's lymphoma; Extranodular involvement; Minimal residual disease; T cell associated antigens; Two color flow cytometry

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035697145     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097741     Document Type: Article

References (94)

1. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas
2. Immunologic classification of leukemia and lymphoma
3. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue
4. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival
5. Surgical pathology examination of lymph nodes
6. Flow cytometric immunophenotyping of non-Hodgkin's lymphoma and related disorders
7. Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes
8. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
9. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
10. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-airlie house, Virginia, November 1997
11. A practical approach to immunophenotyping of lymphoma. Comparison of immunohistologic and immunocytologic techniques
12. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma
13. The aberrancy on immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma
14. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets
15. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology
16. Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas
17. Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma
18. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
19. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: Identification of a new B cell subset
20. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody
21. Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies
22. CD1 expression on B-CLL lymphocytes
23. Diagnostic differentiation of chronic B-cell malignancies using monoclonal antibody L161 (CD1c)
24. The structural biology of CD2
25. Expression of a receptor for sheep erythrocytes by B lymphocytes from a chronic lymphocytic leukemia
26. Simultaneous expression of CD2 on B-cell, small lymphocytic neoplasm
27. Co-expression of CD2 or CD8 antigens in B-cell chronic lymphocytic leukaemia. A flow cytometry analysis of 3 cases
28. Biphenotypic leukemic lymphocyte precursors in CD2+ CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues
29. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression
30. Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood
31. Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
32. The T cell receptor/CD3 complex: A dynamic protein ensemble
33. Molecular biology and function of CD4 and CD8
34. Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells
35. A new human T-cell differentiation antigen: Unexpected expression on chronic lymphatic leukemia cells
36. An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemia cells: Distribution on normal and malignant lymphoid cells
37. Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia
38. Immunologic classification of lymphatic leukemias based on monoclonal antibody-defined cell surface antigens
39. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas
40. Surface markers on leukemia and lymphoma cell: Recent advances
41. The expression of surface antigen Leu-1 by ocular adnexal lymphoid neoplasms
42. The normal and malignant germinal center
43. Expression of a T-cell antigen (Leu-1) by B-cell lymphoma
44. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers
45. Expression of the T1(CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers
46. Intermediate lymphocytic lymphoma. An immunohistologic study with comparison to other lymphocytic lymphomas
47. Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma
48. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations
49. B-cell chronic lymphocytic leukemia: Present status and future directions
50. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data
51. Immunophenotypic classification of chronic (mature) B and T lymphoid leukaemia
52. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct
53. Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia
54. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity
55. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma
56. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation
57. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes
58. De novo CD5-positive diffuse large B-cell lymphoma: Clinical characteristics and therapeutic outcome
59. B-cell lymphoma associated with haemophagocytic syndrome: A clinical, immunological and cytogenetic study
60. B-cell lymphoma-associated hemophagocytic syndrome
61. Biosynthesis and processing of a human T lymphocyte antigen
62. Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development
63. Unusual immunophenotypes in acute leukemias: Incidence and clinical correlations
64. Heterogeneity in a lymphoid tumor: Coexpression of T and B surface markers
65. Abrogation by chemotherapy of T-cell antigen expression in B-cell chronic lymphocytic leukaemia
66. Germ-line configuration of the T-cell receptor beta-chain in B-cell chronic lymphoproliferative disorders which co-express T-cell antigens
67. B-cell chronic lymphocytic leukaemia with aberrant expression of CD8 antigen
68. Aberrant CD8 antigen expression in a patient with B chronic lymphocytic leukaemia showing unusual disease progression
69. CD8-positive B-cell chronic lymphocytic leukemia. A report of two cases
70. Immunophenotypic and molecular genetic characterization of a case of CD8+ B cell chronic lymphocytic leukemia
71. B-cell chronic lymphocytic leukaemia with CD8 expression: Report of 10 cases and immunochemical analysis of the CD8 antigen
72. CD8-positive mantle cell lymphoma: A report of two cases
73. CD8-positive diffuse large B-cell lymphoma
74. A predictive model for aggressive non-Hodgkin's lymphoma
75. Clinical importance of CD7 expression in acute myelocytic leukemia
76. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation
77. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
78. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis
79. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
80. Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma
81. Phase I / II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies
82. Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia
83. A human leukaemic cell expressing hybrid membrane phenotypes
84. Dual B and T markers in chronic lymphocytic leukemia
85. Introduced T cell receptor variable gene segments recombine in pre-B cells: Evidence that B and T cells use a common recombinase
86. Chronic lymphocytic leukemia: New insights into biology and therapy
87. Normal human B cells express endogenous sheep erythrocyte (E) receptor after appropriate in vitro culture
88. Stimulated lymphoma cells of B lineage, but not plasma or myeloid cells, can express E receptor
89. Leu-1+ (CD5+) B cells: A major lymphoid subpopulation in human fetal spleen: Phenotypic and functional studies
90. The CD5 B cell
91. The development and repertoire of B-1 cells (CD5 B cells)
92. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7
93. Chemotherapy-resistant CD7-positive stem cell lymphoma presenting with intra-abdominal mass
94. Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures